Condition: Adrenal Tumors · Adrenocortical Carcinoma · Cushing Syndrome · Sponsor: University of Wuerzburg
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
This description comes directly from the study's public registry record.
Martin Fassnacht, MD · 49-931-201-36507 · fassnacht_m@medizin.uni-wuerzburg.de
Always discuss trial participation with your own doctor first.
| University of Wuerzburg | Würzburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00669266